Fig. 3From: A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles Characterization of Cap-SC VLP-based nanoparticles. AÂ Non-reducing SDS-PAGE and coomassie blue staining analysis of Cap-GFP NPs and Cap-E2 NPs. BÂ TEM negative staining and DLS analysis of Cap-GFP NPs and Cap-E2 NPs. Scale bar: 200Â nmBack to article page